These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 19574605)

  • 1. Implementation of a collaborative drug therapy management service for inpatients receiving direct thrombin inhibitors.
    Cooper T; Taber D; Mazur J
    Am J Health Syst Pharm; 2009 Jul; 66(14):1297-303. PubMed ID: 19574605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and implementation of a comprehensive heparin-induced thrombocytopenia recognition and management protocol.
    Smythe MA; Mehta TP; Koerber JM; Forsyth LL; Sykes E; Corbets LR; Melendy SM; Parikh R
    Am J Health Syst Pharm; 2012 Feb; 69(3):241-8. PubMed ID: 22261947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness outcomes of an inpatient collaborative drug therapy management service for direct thrombin inhibitors.
    Cooper T; White CL; Taber D; Uber WE; Kokko H; Mazur J
    Am J Health Syst Pharm; 2012 Nov; 69(22):1993-8. PubMed ID: 23135566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardizing the management of heparin-induced thrombocytopenia.
    Fugate S; Chiappe J
    Am J Health Syst Pharm; 2008 Feb; 65(4):334-9. PubMed ID: 18238772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Feasibility and Utility of a Pharmacist-Centered Collaborative Drug Therapy Management Program for Oncology-Based Symptom Management.
    Hansen EA; Pietkiewicz JM; Blum BL
    J Pharm Pract; 2016 Jun; 29(3):206-11. PubMed ID: 25510586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Collaborative Drug Therapy Management and Clinical Pharmacy Services in an Outpatient Psychiatric Clinic.
    Tewksbury A; Bozymski KM; Ruekert L; Lum C; Cunningham E; Covington F
    J Pharm Pract; 2018 Jun; 31(3):272-278. PubMed ID: 28539104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a Pharmacist-Directed Anticoagulation Service on the Quality and Safety of Heparin-Induced Thrombocytopenia Management.
    To L; Schillig JM; DeSmet BD; Kuriakose P; Szandzik EG; Kalus JS
    Ann Pharmacother; 2011 Feb; 45(2):195-200. PubMed ID: 21304024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of heparin-induced thrombocytopenia before and after the implementation of a hemostatic and antithrombotic stewardship program.
    Ritchie BM; Sylvester KW; Reardon DP; Churchill WW; Berliner N; Connors JM
    J Thromb Thrombolysis; 2016 Nov; 42(4):616-22. PubMed ID: 27501998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Lewis BE; Hursting MJ
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):57-68. PubMed ID: 17187457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing direct thrombin inhibitors using aPTT, ecarin clotting times, and thrombin inhibitor management testing.
    Gosselin RC; King JH; Janatpour KA; Dager WE; Larkin EC; Owings JT
    Ann Pharmacother; 2004 Sep; 38(9):1383-8. PubMed ID: 15238620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving management strategies for heparin-induced thrombocytopenia.
    Rice L
    Semin Hematol; 2005 Jul; 42(3 Suppl 3):S15-21. PubMed ID: 16105554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Direct inhibition of thrombin. A new strategy for the treatment of atrial fibrillation and acute coronary syndrome?].
    Ahrens I; Bode C
    Herz; 2005 May; 30(3):197-203. PubMed ID: 15902370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and implementation of a nurse-driven, sliding-scale nomogram for bivalirudin in the management of heparin-induced thrombocytopenia.
    Burcham PK; Abel EE; Gerlach AT; Murphy CV; Belcher M; Blais DM
    Am J Health Syst Pharm; 2013 Jun; 70(11):980-7. PubMed ID: 23686604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct thrombin inhibitors for management of heparin-induced thrombocytopenia in patients receiving renal replacement therapy: comparison of clinical outcomes.
    Abel EE; Kane-Gill SL; Seybert AL; Kellum JA
    Am J Health Syst Pharm; 2012 Sep; 69(18):1559-67. PubMed ID: 22935938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bivalirudin.
    Warkentin TE; Greinacher A; Koster A
    Thromb Haemost; 2008 May; 99(5):830-9. PubMed ID: 18449412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The direct thrombin inhibitor hirudin.
    Greinacher A; Warkentin TE
    Thromb Haemost; 2008 May; 99(5):819-29. PubMed ID: 18449411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
    Jeske WP; Walenga JM
    Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.
    Eriksson BI; Dahl OE
    Drugs; 2004; 64(6):577-95. PubMed ID: 15018589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation and evaluation of a collaborative clinical pharmacist's medications reconciliation and charting service for admitted medical inpatients in a metropolitan hospital.
    Khalil V; deClifford JM; Lam S; Subramaniam A
    J Clin Pharm Ther; 2016 Dec; 41(6):662-666. PubMed ID: 27578624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct thrombin inhibitors for anticoagulation.
    Nutescu EA; Wittkowsky AK
    Ann Pharmacother; 2004 Jan; 38(1):99-109. PubMed ID: 14742803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.